1. In Vitro Study of the Metabolic Characteristics of Eight Isoquinoline Alkaloids from Natural Plants in Rat Gut Microbiota
   Chi-Yu He et al, 2017, Molecules CrossRef
2. Metabolic profile of Rhizoma coptidis in human plasma determined using ultra-high-performance liquid chromatography coupled with high-resolution mass spectrometry
   Qing-Shan Zhang et al, 2018, Rapid Commun Mass Spectrom CrossRef
3. Different structures of berberine and five other protoberberine alkaloids that affect P-glycoprotein-mediated efflux capacity
   Yi-ting Zhang et al, 2018, Acta Pharmacol Sin CrossRef
4. Polyphenol Microbial Metabolites Exhibit Gut and Blood–Brain Barrier Permeability and Protect Murine Microglia against LPS-Induced Inflammation
   Shelby L. Johnson et al, 2019, Metabolites CrossRef
5. Rhizoma coptidis as a Potential Treatment Agent for Type 2 Diabetes Mellitus and the Underlying Mechanisms: A Review
   Qian Ran et al, 2019, Front. Pharmacol. CrossRef
6. Palmatine: A review of pharmacological properties and pharmacokinetics
   Dominik Tarabasz et al, 2019, Phytotherapy Research CrossRef
7. The metabolism of berberine and its contribution to the pharmacological effects
   Kun Wang et al, 2017, Drug Metabolism Reviews CrossRef
8. Identification of components and metabolites in plasma of type 2 diabetic rat after oral administration of Jiao‐Tai‐Wan using ultra‐performance liquid chromatography/quadrupole time‐of‐flight mass spectrometry
   Zhihui Li et al, 2020, J. Sep. Sci. CrossRef
9. Brij-functionalized chitosan nanocarrier system enhances the intestinal permeability of P-glycoprotein substrate-like drugs
   Wei Xiong et al, 2021, Carbohydrate Polymers CrossRef
10. Comparison of Pinoresinol and its Diglucoside on their ADME Properties and Vasorelaxant Effects on Phenylephrine-Induced Model
    Yiqiong Pu et al, 2021, Front. Pharmacol. CrossRef
11. Antitumor efficiency of the natural alkaloid berberine complexed with C60 fullerene in Lewis lung carcinoma in vitro and in vivo
    Anna Grebinyk et al, 2021, Cancer Nano CrossRef
12. Palmatine, a Bioactive Protoberberine Alkaloid Isolated from Berberis cretica, Inhibits the Growth of Human Estrogen Receptor-Positive Breast Cancer Cells and Acts Synergistically and Additively with Doxorubicin
    Aneta Grabarska et al, 2021, Molecules CrossRef
13. Jatrorrhizine: A Review of Sources, Pharmacology, Pharmacokinetics and Toxicity
    Furong Zhong et al, 2022, Front. Pharmacol. CrossRef
14. Berberine: A Review of its Pharmacokinetics Properties and Therapeutic Potentials in Diverse Vascular Diseases
    Xiaopeng Ai et al, 2021, Front. Pharmacol. CrossRef
15. Development of novel 9-O-substituted-13-octylberberine derivatives as potential anti-hepatocellular carcinoma agents
    Jichao Chen et al, 2022, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
16. Potential bioactive compounds and mechanisms of Fibraurea recisa Pierre for the treatment of Alzheimer’s disease analyzed by network pharmacology and molecular docking prediction
    Shishuai Wang et al, 2022, Front. Aging Neurosci. CrossRef
17. Approaching strategy to increase the oral bioavailability of berberine, a quaternary ammonium isoquinoline alkaloid: Part 1. Physicochemical and pharmacokinetic properties
    Teruo Murakami et al, 2023, Expert Opinion on Drug Metabolism & Toxicology CrossRef
18. Studies on synthesis, physicochemical properties, biological activities of two novel berberine-based salts with DL-mandelate and cinnamate anions
    Huanhuan Lu et al, 2023, Journal of Molecular Structure CrossRef
19. Characterization and Pharmacokinetic Assessment of a New Berberine Formulation with Enhanced Absorption In Vitro and in Human Volunteers
    Julia Solnier et al, 2023, Pharmaceutics CrossRef
20. Targeting Alzheimer’s Disease: Evaluating the Efficacy of C-1 Functionalized N-Aryl-Tetrahydroisoquinolines as Cholinergic Enzyme Inhibitors and Promising Therapeutic Candidates
    Dunja Jovanović et al, 2024, IJMS CrossRef
21. Protoberberine alkaloids: A review of the gastroprotective effects, pharmacokinetics, and toxicity
    Ze-dong Xiang et al, 2024, Phytomedicine CrossRef
22. Physicochemical properties and biological activities of new berberine-based salts with syringic acid as well as 3,5-dimethoxybenzoic acid as anions: Effect of temperature, concentration and anion
    Zhenning Yan et al, 2024, Journal of Molecular Liquids CrossRef
23. Selenium-Methionine-Folic Acid Nanoparticles (SeMetFa NPs) and Its In Vivo Efficacy Against Rheumatoid Arthritis
    Vrundali Shinde et al, 2024, Biol Trace Elem Res CrossRef
24. Recent Advances in Berberine Inspired Anticancer Approaches: From Drug Combination to Novel Formulation Technology and Derivatization
    Solomon Habtemariam, 2020, Molecules CrossRef
25. Delocalized quinolinium-macrocyclic peptides, an atypical chemotype for CNS penetration
    Valeria Pingitore et al, 2024, Sci. Adv. CrossRef
26. 9-Hydroxy-8-oxypalmatine, a novel liver-mediated oxymetabolite of palmatine, alleviates hyperuricemia and kidney inflammation in hyperuricemic mice
    Xiaoyan Wu et al, 2024, Journal of Ethnopharmacology CrossRef
27. 13-Methylpalmatine improves myocardial infarction injury by inhibiting CHOP-mediated cross-talk between endoplasmic reticulum and mitochondria
    Zefeng Jiang et al, 2024, Biomedicine & Pharmacotherapy CrossRef
28. Evaluation of anti-tumor activity of molybdenum disulfide nanoflowers per se and in combination with berberine against mammary gland cancer in rats
    Amna Roheel et al, 2024, J Nanopart Res CrossRef
29. Botanical Sources, Pharmacokinetics, and Therapeutic Efficacy of Palmatine and Its Derivatives in the Management of Cancer: A Comprehensive Mechanistic Analysis
    Most. Israt Jahan Oni et al, 2024, Journal of Food Biochemistry CrossRef